trending Market Intelligence /marketintelligence/en/news-insights/trending/5UfsjAbc6rXyV9YdpmLprw2 content esgSubNav
In This List

Real Nutriceutical H1 profit falls YOY

Podcast

Private Markets 360 | Episode 6: Benchmarking private investment performance

Case Study

A European Bank Leverages an AIF Scorecard to Help Meet Basel Regulatory Requirements

Case Study

Powering the markets of the future with data and AI

Blog

Analyzing Sentiment in Quarterly Earnings Calls — Q3 2023


Real Nutriceutical H1 profit falls YOY

Real Nutriceutical Group Ltd said its first-half normalized net income came to 4 fen per share, a decrease of 75.6% from 18 fen per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 69.2 million yuan, a decrease of 69.4% from 226.3 million yuan in the year-earlier period.

Total revenue fell 40.5% on an annual basis to 649.2 million yuan from 1.09 billion yuan, and total operating expenses decreased 25.7% on an annual basis to 538.4 million yuan from 724.7 million yuan.

Reported net income fell 72.2% from the prior-year period to 68.5 million yuan, or 4 fen per share, from 246.7 million yuan, or 19 fen per share.

As of Sept. 22, US$1 was equivalent to 6.67 yuan.